Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5875
|
| pubmed:dateCreated |
1982-9-17
|
| pubmed:keyword | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
E
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0028-0836
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
12
|
| pubmed:volume |
298
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
595
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:otherAbstract |
KIE: Further doubt has been cast on the validity of the original Cohen-Boyer genetic engineering patent by the U.S. Patent Office's recent decision to reject a related patent application. A potential defect found in the second patent presumably exists in the first as well. Stanford University, which has three months to respond to the Patent Office's action, does not see any "insurmountable obstacles" to obtaining the patent rights.
|
| pubmed:meshHeading | |
| pubmed:year |
1982
|
| pubmed:articleTitle |
More trouble for Stanford's patent.
|
| pubmed:publicationType |
News
|